Providence Therapeutics

Providence Therapeutics is an mRNA Medicines Platform company with over nine years of expertise in the mRNA field. The company has a proven mRNA Medicines Platform and a next-generation lipid nanoparticle (LNP) technology that is designed to stimulate immune responses to cancers and infectious diseases.
Moreover, Providence has manufacturing and regulatory platforms that can produce mRNA-based vaccines and therapeutics ranging from personalized to pandemic scales. Providence has a pipeline of partnered and internal program in oncology, infectious diseases and animal health. The company also partners for target discovery with academic institutes and industry partners for co-development and LNP licensing.